GMP Update: Reducing Obstacles to Innovation

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-10-02-2003, Volume 27, Issue 10

FDA offers new policies to encourage modern manufacturing approaches and automated systems, to simplify postapproval changes, and to avoid problems with sterile products.

Related Content:

Regulatory/GMP ComplianceRegulatory WatchPharmaceutical Technology-10-02-2003
Ask the Expert: Complying with 21 CFR 211.110
FDA Warns Sanofi About API CGMP Deviations, Issues Clinical Hold on Atara Immunotherapies
Sustainability in Pharmaceutical Manufacturing